]>
IRCT20180107038251N8 IRCT 2023-06-12 Arak University of Medical Sciences Effect of topical application of piroxicam gel, diclofenac gel and emla on pain relief Comparison of the effect of topical application of piroxicam gel, diclofenac gel and emla on pain relief of angiocatheter insertion in patients 2023-06-21 anticipated 123 Complete https://irct.ir/trial/68841 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: In order to randomly assign the samples in three groups, we prepare beads of the same gender and the same shape as the number of samples and write the number of the desired group on each one, then we put the beads in a container and ask the research units to take out one of the beads and in this way the samples will be randomly placed in one of the three groups, Blinding description: After determining the patient group for blinding, the researcher will cover the tube of intervention drugs with paper covers and then apply the desired drug in each group. N/A intensity of pain. Intervention 1: Intervention group:Piroxicam (P), in the amount of 10 mg of piroxicam gel, is placed in the desired place (veins on the back of the hand) in dimensions of 2 x 4 cm. Intervention 2: Intervention group:Diclofenac (D), 100 mg of diclofenac gel is placed in the desired place (veins on the back of the hand) in dimensions of 2x4 cm. Intervention 3: Intervention group:Emla (E), 1.5 grams of cream is placed in the desired place (veins on the back of the hand) in dimensions of 2 x 4 cm. Yes - There is a plan to make this available What will be shared: The total potential data can be shared after unidentifiable people When: 2024 To whom: En Researchers working in academia and academia Conditions: I have no conditions Where to obtain: Arak University of Medical Sciences, Alamoll Huda Street, Railroad Street Arak, Markazi Province, Iran How to obtain: Visit to Arak Medical University, Faculty of Paramedicine, Anesthesiology Department, Ms. Amini Comments:
public Nazanin Amini
Arak University of Medical Sciences, Alamoll Huda Street, Railroad Street, Arak, Iran
Arak Iran (Islamic Republic of) 1234 +98 86 3417 3507 nazaninamini69@yahoo.com Arak University of Medical Sciences scientific Dr Hesameddin Modir
Arak University of Medical Sciences, Alamoll Huda Street, Railroad Street, Arak, Iran
Arak Iran (Islamic Republic of) 1234 +98 86 3417 3507 modir.he@gmail.com Arak University of Medical Sciences Iran (Islamic Republic of) Age range from 15 to 65 years of old ASA I , II Absence of pain for any reason Absence of verbal, mental and visual disability Absence of pregnancy No history of drug abuse Not using painkillers in the last 24 hours Absence of sensitivity to NSAID Absence of sensitivity to local anesthetics Absence of allergy to vitamin A + D ointment 15 years 65 years Both Lack of patient consent to participate or continue the study Body mass index more than 30 Presence of peripheral vascular disease and Raynaud's syndrome The presence of scleroderma Failure of the researcher in the first attempt at cannulation G89 Pain, not elsewhere classified Prevention Prevention Prevention Intervention group:Piroxicam (P), in the amount of 10 mg of piroxicam gel, is placed in the desired place (veins on the back of the hand) in dimensions of 2 x 4 cm. Intervention group:Diclofenac (D), 100 mg of diclofenac gel is placed in the desired place (veins on the back of the hand) in dimensions of 2x4 cm. Intervention group:Emla (E), 1.5 grams of cream is placed in the desired place (veins on the back of the hand) in dimensions of 2 x 4 cm. Intensity of pain. Timepoint: at 0, 5, 10, 15, 30, and 45 minutes after cannulation. Method of measurement: Visual Analogue Scale. Arak University of Medical Sciences Approved 2023-01-08 Ethics committee of Arak University of Medical Sciences Arak University of Medical Sciences, Alamoll Huda Street, Railroad Street, Arak, Iran Arak Markazi Iran (Islamic Republic of)